FDA approves remote heart monitoring device
Eko Devices, a tech company in Berkeley, California, has received U.S. Food and Drug Administration (FDA) approval for its combined digital stethoscope and electrocardiogram that can be used from home, reports Qmed.
The handheld device links to a smartphone app that wirelessly transmits heart sounds and electrical activity to a physician for remote monitoring. The device can help reduce heart failure and atrial fibrillation. Eko is the company to release one of the first smart stethoscopes.
“I’m excited about the device,” said University of California, San Francisco cardiologist John Chorba. “I see it primarily as a great way to capture the heart sounds and some electrocardiographic findings in a very user-friendly way.”
To read the full story, follow the link below.
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.